Effect of Implementing Prevention Measures Through Personalized Information in Emergency Departments on Adherence to Prevention Measures

ConditionPrevention
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier le Mans

About this trial

Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed.

Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures.

Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures.

The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients (≥ 18 years of age)

Patients seen in the emergency departments of Le Mans University Hospital and the PSSL

Patients who have given their free and informed oral consent

Disqualifiers

Patients who have previously participated in the study

Patients with limited understanding of the French language

Patients unable to give informed consent

Individuals not enrolled in or not eligible for a social security program

Trial design

Design model

Parallel

Treatments tested in this trial

  • personalized preventive health information

    Procedure/Surgery

    The intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use.

  • non-personalized preventive health information

    Procedure/Surgery

    The intervention involves providing non-personalized preventive health information. The patient receives all the preventive health information without it being tailored to the patient. The patient therefore does not see any information specific to him or her.

Treatment groups

658 Participants
are divided into 2 treatment groups
Group A: A - InterventionExperimental treatment 1 intervention
Group B: B - ControlExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

proportion of patients who adhered to at least 25% of the preventive measures

The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention. Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term

Time frame
6-8 weeks after the intervention.

Secondary outcomes

1

The proportion of patients who adhered to each of the preventive measures studied.

Time frame
6-8 weeks after the intervention.
2

The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible.

Time frame
6-8 weeks after the intervention.
3

The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status).

Time frame
6-8 weeks after the intervention.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: